Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)
Clinical trial NCT03608397 · COMPLETED
Trial details
- NCT number
- NCT03608397
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-20
- Primary completion
- 2019-12-03
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.